Emollient bath additives provide minimal or no clinical benefit when added to standard eczema care in children, finds a trial published by in the BMJ.
The study included 482 children ages 1 to 11 years being treated for moderate eczema. Children randomized to the intervention group were prescribed 1 of 3 emollient bath additives to be used for a year. The control group used no bath additives. Both groups continued with standard eczema management, and caregivers received advice on how to wash participants.
Slomski A. Bath Emollients Offer Little Added Benefit in Pediatric Eczema. JAMA. 2018;319(24):2470. doi:10.1001/jama.2018.7938
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: